Press release
13 Sep 2023
Ahead of UN General Assembly, pharmaceutical industry underscores need for pandemic preparedness plans to support innovation and equity
Ahead of discussions at the United Nations General Assembly (UNGA78), the trade association representing the innovative pharmaceutical industry, the IFPMA, has warned that current pandemic preparedness plans should not undermine what worked well in response to COVID-19 and must support both “innovation and equity.”
Read more
Statement
9 Jun 2023
First-of-its-kind event brings together 10 companies that partnered to deliver vaccines and treatments in response to COVID-19
On 7 June 2023, IFPMA hosted a unique opportunity to hear from 10 companies, about the different partnership models that supported the industry’s response to COVID-19. This open event included discussion on the challenges of scaling up manufacturing to meet global demand for vaccines and treatments, with representatives from MSD – Dr Reddy’s Laboratories; Gilead...
Read more
Position paper
15 May 2023
IFPMA Note for Guidance on sponsorship of events and meetings (2023 update)
Collaborations between healthcare professionals (HCPs) and the pharmaceutical industry are essential and ensure that patients have access to the medicines they need and that healthcare professionals have up-to-date comprehensive information about the diseases they treat and the medicines they prescribe.
Read more
